Swanbridge Capital invests in Immagene

by | Sep 29, 2020 | Blog

Official launch of Immagene: Dutch company developing next-generation immuno-oncology therapeutics   Immagene B.V. launched this month as a private biotech company developing next-generation precision immuno-oncology (IO) treatments. The company based in...